vs
Definitive Healthcare Corp.（DH）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Definitive Healthcare Corp.的1.2倍（$75.5M vs $61.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -1.2%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-1.7M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -1.5%）
该企业是一家美国公司，主打非处方医疗健康产品与家居清洁产品的营销和分销。公司于1996年由美德泰产品公司、威望品牌国际与斯皮克Span公司合并成立，总部设在纽约塔里敦，在弗吉尼亚州林奇堡设有生产工厂。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
DH vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.2倍
$61.5M
营收增速更快
PBYI
高出28.9%
-1.2%
自由现金流更多
PBYI
多$16.1M
$-1.7M
两年增速更快
PBYI
近两年复合增速
-1.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $61.5M | $75.5M |
| 净利润 | $-9.3M | — |
| 毛利率 | 76.2% | 69.3% |
| 营业利润率 | -43.3% | 22.7% |
| 净利率 | -15.1% | — |
| 营收同比 | -1.2% | 27.7% |
| 净利润同比 | 84.2% | — |
| 每股收益（稀释后） | $-0.14 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DHPBYI
| Q4 25 | $61.5M | $75.5M | ||
| Q3 25 | $60.0M | $54.5M | ||
| Q2 25 | $60.8M | $52.4M | ||
| Q1 25 | $59.2M | $46.0M | ||
| Q4 24 | $62.3M | $59.1M | ||
| Q3 24 | $62.7M | $80.5M | ||
| Q2 24 | $63.7M | $47.1M | ||
| Q1 24 | $63.5M | $43.8M |
净利润DHPBYI
| Q4 25 | $-9.3M | — | ||
| Q3 25 | $-14.8M | $8.8M | ||
| Q2 25 | $-7.6M | $5.9M | ||
| Q1 25 | $-107.2M | $3.0M | ||
| Q4 24 | $-59.1M | — | ||
| Q3 24 | $-130.9M | $20.3M | ||
| Q2 24 | $-213.6M | $-4.5M | ||
| Q1 24 | $-9.5M | $-4.8M |
毛利率DHPBYI
| Q4 25 | 76.2% | 69.3% | ||
| Q3 25 | 76.6% | 77.7% | ||
| Q2 25 | 76.7% | 76.5% | ||
| Q1 25 | 73.9% | 77.1% | ||
| Q4 24 | 76.4% | 76.4% | ||
| Q3 24 | 78.2% | 63.9% | ||
| Q2 24 | 79.2% | 77.4% | ||
| Q1 24 | 79.4% | 75.5% |
营业利润率DHPBYI
| Q4 25 | -43.3% | 22.7% | ||
| Q3 25 | -14.5% | 17.6% | ||
| Q2 25 | -6.9% | 12.7% | ||
| Q1 25 | -312.2% | 8.7% | ||
| Q4 24 | -159.8% | 22.6% | ||
| Q3 24 | -359.5% | 27.4% | ||
| Q2 24 | -579.9% | -4.6% | ||
| Q1 24 | -25.6% | -5.3% |
净利率DHPBYI
| Q4 25 | -15.1% | — | ||
| Q3 25 | -24.7% | 16.2% | ||
| Q2 25 | -12.4% | 11.2% | ||
| Q1 25 | -181.2% | 6.5% | ||
| Q4 24 | -94.8% | — | ||
| Q3 24 | -208.8% | 25.2% | ||
| Q2 24 | -335.2% | -9.6% | ||
| Q1 24 | -15.0% | -11.0% |
每股收益（稀释后）DHPBYI
| Q4 25 | $-0.14 | $0.26 | ||
| Q3 25 | $-0.14 | $0.17 | ||
| Q2 25 | $-0.07 | $0.12 | ||
| Q1 25 | $-0.95 | $0.06 | ||
| Q4 24 | $-0.53 | $0.40 | ||
| Q3 24 | $-1.12 | $0.41 | ||
| Q2 24 | $-1.81 | $-0.09 | ||
| Q1 24 | $-0.08 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $180.9M | $97.5M |
| 总债务越低越好 | $156.1M | $22.7M |
| 股东权益账面价值 | $379.0M | $130.3M |
| 总资产 | $735.5M | $216.3M |
| 负债/权益比越低杠杆越低 | 0.41× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资DHPBYI
| Q4 25 | $180.9M | $97.5M | ||
| Q3 25 | $185.9M | $94.4M | ||
| Q2 25 | $184.2M | $96.0M | ||
| Q1 25 | $200.7M | $93.2M | ||
| Q4 24 | $290.2M | $101.0M | ||
| Q3 24 | $305.4M | $96.7M | ||
| Q2 24 | $296.5M | $96.8M | ||
| Q1 24 | $295.2M | $107.2M |
总债务DHPBYI
| Q4 25 | $156.1M | $22.7M | ||
| Q3 25 | $158.2M | $34.0M | ||
| Q2 25 | $160.3M | $45.3M | ||
| Q1 25 | $162.4M | $56.7M | ||
| Q4 24 | $229.4M | $68.0M | ||
| Q3 24 | $232.7M | $79.3M | ||
| Q2 24 | $236.0M | $90.7M | ||
| Q1 24 | $239.3M | $102.0M |
股东权益DHPBYI
| Q4 25 | $379.0M | $130.3M | ||
| Q3 25 | $389.7M | $115.3M | ||
| Q2 25 | $411.2M | $104.7M | ||
| Q1 25 | $435.9M | $97.1M | ||
| Q4 24 | $607.2M | $92.1M | ||
| Q3 24 | $695.6M | $71.1M | ||
| Q2 24 | $886.3M | $48.5M | ||
| Q1 24 | $1.2B | $51.0M |
总资产DHPBYI
| Q4 25 | $735.5M | $216.3M | ||
| Q3 25 | $755.5M | $202.9M | ||
| Q2 25 | $770.1M | $194.9M | ||
| Q1 25 | $808.7M | $196.2M | ||
| Q4 24 | $1.1B | $213.3M | ||
| Q3 24 | $1.2B | $220.7M | ||
| Q2 24 | $1.4B | $205.0M | ||
| Q1 24 | $1.8B | $214.1M |
负债/权益比DHPBYI
| Q4 25 | 0.41× | 0.17× | ||
| Q3 25 | 0.41× | 0.30× | ||
| Q2 25 | 0.39× | 0.43× | ||
| Q1 25 | 0.37× | 0.58× | ||
| Q4 24 | 0.38× | 0.74× | ||
| Q3 24 | 0.33× | 1.12× | ||
| Q2 24 | 0.27× | 1.87× | ||
| Q1 24 | 0.20× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.7M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-1.7M | $14.4M |
| 自由现金流率自由现金流/营收 | -2.8% | 19.1% |
| 资本支出强度资本支出/营收 | 7.2% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $37.1M | $41.7M |
8季度趋势，按日历期对齐
经营现金流DHPBYI
| Q4 25 | $2.7M | $14.4M | ||
| Q3 25 | $15.7M | $9.7M | ||
| Q2 25 | $9.3M | $14.1M | ||
| Q1 25 | $26.1M | $3.6M | ||
| Q4 24 | $8.1M | $15.6M | ||
| Q3 24 | $19.4M | $11.0M | ||
| Q2 24 | $14.0M | $1.0M | ||
| Q1 24 | $16.6M | $11.2M |
自由现金流DHPBYI
| Q4 25 | $-1.7M | $14.4M | ||
| Q3 25 | $13.4M | $9.7M | ||
| Q2 25 | $7.0M | $14.1M | ||
| Q1 25 | $18.4M | $3.6M | ||
| Q4 24 | $-2.8M | $15.6M | ||
| Q3 24 | $18.7M | $11.0M | ||
| Q2 24 | $13.6M | $1.0M | ||
| Q1 24 | $16.3M | — |
自由现金流率DHPBYI
| Q4 25 | -2.8% | 19.1% | ||
| Q3 25 | 22.3% | 17.7% | ||
| Q2 25 | 11.5% | 26.8% | ||
| Q1 25 | 31.0% | 7.7% | ||
| Q4 24 | -4.4% | 26.4% | ||
| Q3 24 | 29.8% | 13.7% | ||
| Q2 24 | 21.4% | 2.1% | ||
| Q1 24 | 25.7% | — |
资本支出强度DHPBYI
| Q4 25 | 7.2% | 0.0% | ||
| Q3 25 | 3.8% | 0.0% | ||
| Q2 25 | 3.8% | 0.0% | ||
| Q1 25 | 13.0% | 0.1% | ||
| Q4 24 | 17.5% | 0.0% | ||
| Q3 24 | 1.2% | 0.0% | ||
| Q2 24 | 0.6% | 0.0% | ||
| Q1 24 | 0.4% | 0.0% |
现金转化率DHPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DH
| Subscription Services | $58.5M | 95% |
| Professional Services | $3.0M | 5% |
PBYI
暂无分部数据
